Previous 10 | Next 10 |
home / stock / imexf / imexf news
Some of the most commonly used medications, such as antibiotics, are usually administered in low doses , despite the greater therapeutic benefit they possess, because of the risk of arrhythmias. Arrhythmias occur when an individual’s heartbeat becomes irregular , beating either too ...
Imagin Medical (CSE: IME) (OTCQB: IMEXF) , a surgical imaging company focused on establishing a new standard of care in visualizing cancer during minimally invasive procedures, today announced continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging. Per ...
Vancouver, B.C. and Boston, MA, May 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards commercial-stage manu...
Imagin Medical (CSE: IME) (OTCQB: IMEXF) , a surgical imaging company, was featured in a recent article that discussed its timely progress toward 2022 completion of its innovative i/Blue Imaging System(TM). The patented system is designed leveraging proprietary light sensors and optics to i...
We spend a large chunk of our lifetimes asleep — the average person spends around 26 years of their life snoozing, and all this sleep has a major impact on our bodies. Not only does sleep allow us to replenish and recharge after a tiring day, but it is also the time when the body pu...
Approximately 50% of patients who have bladder cancer will see a recurrence of the condition – often due to poor margin visibility White light has been the standard procedure during cystoscopies, but is only beneficial if tumors protrude from the bladder wall Blue light cystosc...
Bladder cancer is still the sixth most prevalent cancer in the U.S. in 2021 The total number of new bladder cancer cases is expected to reach 83,730, with deaths totaling 17,200 this year Imagin Medical Inc. is hoping to offer a better standard of care for bladder cancer patients with...
Imagin Medical’s contract manufacturer, Lighthouse Imaging, has developed a program focused on refining the i/Blue System’s design for manufacturing Lighthouse’s manufacturing process will ensure that regulatory standards are followed while maintaining optimal perfo...
Imagin Medical (CSE: IME) (OTCQB: IMEXF) , a surgical imaging company, has made notable strides in its quest to offer innovative technology for visualizing cancer. Designed to address the limitations of both white and blue light cystoscopy procedures, IME’s i/Blue(TM) Imaging System ...
A recent study has found a clear link between a higher risk of dying from illnesses of the heart and blood vessels and the duration and frequency of unconscious wakefulness throughout night-time sleep. The researchers discovered that in comparison with the general female population, wome...
News, Short Squeeze, Breakout and More Instantly...
Imagin Medical Inc Company Name:
IMEXF Stock Symbol:
OTCMKTS Market:
2024-03-27 17:08:02 ET Surgical imaging for bladder cancer Imagin Medical is a surgical imaging company. They're focusing on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company’s initially focused on bladder ca...
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin PR Newswire Ponce Therapeutic's (" Ponce ") lead product, ReBea...
Imagin Medical Announces Stock Option Grants PR Newswire VANCOUVER , BC and BOSTON , April 22, 2022 /PRNewswire/ -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) ( Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today...